Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

MANNITOL 25% Drug Profile

« Back to Dashboard

Which patents cover Mannitol 25%, and what generic alternatives are available?

Mannitol 25% is a drug marketed by Luitpold, Merck, Igi Labs Inc, Intl Medication, Abraxis Pharm, Watson Labs, Hospira, and Fresenius Kabi Usa. and is included in nine NDAs.

The generic ingredient in MANNITOL 25% is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for Tradename: MANNITOL 25%

Suppliers / Packagers: see list5
Bulk Api Vendors: see list78
Clinical Trials: see list51
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MANNITOL 25% at DailyMed

Pharmacology for Tradename: MANNITOL 25%

Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
INJECTABLE;INJECTION087409-001Jan 21, 1982APRXNoNo► Subscribe► Subscribe
Watson Labs
INJECTABLE;INJECTION087460-001Jun 27, 1983DISCNNoNo► Subscribe► Subscribe
Igi Labs Inc
INJECTABLE;INJECTION089240-001May 6, 1987DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION016269-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION005620-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus